Skip to main content
Clinical Trials/JPRN-UMIN000050523
JPRN-UMIN000050523
Not yet recruiting
未知

Risk factors for the development and severity of interstitial lung disease associated with EGFR tyrosine kinase inhibitors in non-small cell lung cancer: a systematic review and meta-analysis - Risk factors for the development and severity of interstitial lung disease associated with EGFR tyrosine kinase inhibitors in non-small cell lung cancer: a systematic review and meta-analysis

Showa University0 sitesMarch 13, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
EGFR tyrosine kinase inhibitor-associated interstitial lung disease
Sponsor
Showa University
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 13, 2023
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Others,meta-analysis etc
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Pediatric patients under 18 years of age Adult patients with histopathologically diagnosed small\-cell lung cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials